Technology has come to the rescue, quite literally, in the form of a drug discovery tool created at Cincinnati Children’s ...
Move over, Hugh Laurie: there’s a new Dr. House in town. Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Rare and undiagnosed diseases affect over 300 million people globally, posing an immense human and economic burden. These conditions, while individually rare, collectively represent a massive health ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Harvard Medical School researcher Marinka Zitnik discusses a new AI model for drug repurposing. The approach can help expedite drug discovery for rare diseases. There are more than 7,000 rare and ...
Glioblastoma, an aggressive brain cancer, has a very poor prognosis. More than 95% of glioblastoma patients die within five years of diagnosis. Glioblastoma has an incidence rate of 3.19 per 100,000 ...
Cory Simpson, MD, PhD, assistant professor of dermatology at the University of Washington, spoke to the need for more treatment options in genetic skin conditions and the possibility of drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results